Pharmacy

Your Article Summary

See Latest Articles

Enzon Commences Phase II Trial of PEG-SN38
Enzon Pharmaceuticals, 06/23/09

Enzon Pharmaceuticals, Inc. announced that it has opened its first Phase II trial for PEG-SN38, its novel proprietary cancer compound. The trial is open at multiple centers throughout the United States for patients diagnosed with metastatic colon cancer.

Today in Chemotherapy/Oncology...keeping you current

Receive free subspecialty "5-minute updates" via email

Palliative Oncology: Thalidomide
American Journal of Hospice and Palliative Medicine, 10/21/09

Current status of maintenance therapy for advanced ovarian cancer
International Journal of Women's Health, 11/03/09

Aspirin use associated with lower colorectal cancer mortality
American Pharmacists Association, 10/14/09

See All of Chemotherapy/Oncology

Today in Drug Trials...keeping you current

Receive free subspecialty "5-minute updates" via email

Phase I Biodistribution and Pharmacokinetic Study of Lewis Y–Targeting Immunoconjugate CMD-193 in Patients with Advanced Epithelial Cancers
Clinical Cancer Research, 10/19/09

A Randomized Trial of Doxycycline for Mansonella perstans Infection
New England Journal of Medicine, 10/08/09

Microbicides Development Programme: design of a phase III trial to measure the efficacy of the vaginal microbicide PRO 2000/5 for HIV prevention
Trials, 10/28/09

See All of Drug Trials

Today in Stomach/GI...keeping you current

Receive free subspecialty "5-minute updates" via email

Salix Receives FDA Marketing Approval for Metozolv
Salix Pharmaceuticals, 09/10/09

Methotrexate for maintenance of remission in Crohn's disease
Cochrane Reviews, 10/27/09

Monotherapy versus combination therapy for the treatment of chronic hepatitis B
Expert Opinion on Investigational Drugs, 10/26/09

See All of Stomach/GI